Publications
18
Citations
156
Est. group size
~9
Recurring co-author estimate
Active years
10
Publishing since 2017
Jana M. Cable's research focuses on how the Epstein-Barr virus (EBV), a herpesvirus linked to certain cancers, manipulates human immune cells to cause disease, including how viral proteins alter the structure of host DNA (chromatin) and hijack cellular processes to transform normal B cells into cancer-like cells. Related work explores how the immune system fights back against herpesviruses, and includes studies of viral-driven lymphomas and engineered virus-based cancer therapies. This work would suit students interested in virology, cancer biology, immunology, or molecular biology of gene regulation.
Publication output was sparse and irregular in the early part of the decade but has increased notably since 2023, with the highest output in 2024-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Sp140L functions as a herpesvirus restriction factor suppressing viral transcription and activating interferon-stimulated genes
Proceedings of the National Academy of Sciences · 2025
- EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation
Nucleic Acids Research · 2025
- EBNA2 and EBNA-LP: The Earliest Viral Latency Proteins
Current topics in microbiology and immunology · 2025
- Epstein-Barr virus protein EBNA-LP engages YY1 through leucine-rich motifs to promote naïve B cell transformation
PLoS Pathogens · 2024
- Sp140L Is a Novel Herpesvirus Restriction Factor
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Epstein-Barr virus protein EBNA-LP engages YY1 through leucine-rich motifs to promote naïve B cell transformation
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Epstein-Barr virus induces germinal center light zone chromatin architecture and promotes survival through enhancer looping at the <i>BCL2A1</i> locus
mBio · 2023
- Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas
Proceedings of the National Academy of Sciences · 2021
- Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity
Nature Communications · 2020
- Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas
bioRxiv (Cold Spring Harbor Laboratory) · 2020
- THER-05. GENETICALLY STABLE POLIOVIRUS VECTOR CARRYING H3.3K27M ANTIGEN FOR TREATMENT OF DIFFUSE MIDLINE GLIOMA BY INTRAMUSCULAR INJECTION
Neuro-Oncology · 2020
- Calcium-Dependent Interaction Occurs between Slow Skeletal Myosin Binding Protein C and Calmodulin
Magnetochemistry · 2017
- bioRxiv (Cold Spring Harbor Laboratory)×5
- Proceedings of the National Academy of Sciences×2
- Nature Communications×2
- PLoS Pathogens×1
- Nucleic Acids Research×1
- Matthew R. Olson
Medicine · Purdue University West Lafayette
- Luopin Wang
Medicine · Purdue University West Lafayette
- Leona W. Ayers
Medicine · The Ohio State University
- Srishti Chakravorty
Medicine · Purdue University West Lafayette
- Toby Maurer
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile